Medications

Hepatitis C drug faces fresh battle

Medical groups mounted a new legal bid Monday to break a US pharma giant's hold on a hepatitis C drug whose price—costing thousands of dollars for a typical course—has unleashed a fierce patent battle.

Mar 27, 2017
popularity8 comments 0

Could targeting oxtyocin help treat opioid addiction?

A new review of published research indicates that the oxytocin system—a key player in social reward and stress regulation—is profoundly affected by opioid use. Therefore, it may be an important target for developing medications ...

Apr 05, 2017
popularity1 comments 1